KINOX

This brand name is authorized in Canada, France.

Active ingredients

The drug KINOX contains one active pharmaceutical ingredient (API):

1	Nitric oxide (NO) UNII 31C4KY9ESH - NITRIC OXIDE
	Nitric oxide is a compound produced by many cells of the body. It relaxes vascular smooth muscle by binding to the haeme moiety of cytosolic guanylate cyclase. When inhaled, nitric oxide produces selective pulmonary vasodilation.
	Read more about Nitric oxide (NO)

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
KINOX Inhalation gas	MPI, CA: SPM	Health Products and Food Branch (CA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R07AX01	Nitric oxide	R Respiratory system → R07 Other respiratory system products → R07A Other respiratory system products → R07AX Other respiratory system products
Discover more medicines within R07AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02451301, 02451328
FR	Base de données publique des médicaments	66393084, 69399740